Floatz logo

Whole-Cell Pertussis Vaccine

Pertussis

National Institute of Allergy and Infectious Diseases (NIAID)vaccinePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pertussis cohort.

Asset / SponsorPhaseRating
HUMAN IMMUNOGLOBULINS
IWK Health Centre
Phase 3B
Dtpw-Hbv/Hib-Menac Conjugate Vaccine
GlaxoSmithKline
Phase 2B

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →